Skip to main content

Table 3 Maintenance dose weeks 1–4 (n = 64)

From: A retrospective evaluation of patients switched from buprenorphine (subutex) to the buprenorphine/naloxone combination (suboxone)

  n (%)
Treated with Suboxone only throughout 4-week study period 53 (82.8)
Stayed at same dose of Suboxone only throughout 4-week study period 46 (71.9)
Dose reduction 4 (6.3)
Dose increase 1 (1.1)
Temporary dose change 2 (3.1)
Titrated1 with Subutex throughout 4-week study period 7 (11)
Discontinued treatment with Suboxone during 4-week study period 4 (6.2)
  1. 1patients had at the same time Suboxone and Subutex, first day 50:50 and during the first week gradually to Suboxone only